Amrutanjan Health Care Limited · NSE:AMRUTANJAN
Amrutanjan Health Care — Q3 FY24 Earnings Presentation
27 slides from Amrutanjan Health Care's earnings presentation, Feb 10, 2024
Slide 1: Cover letter to stock exchanges
AHCL/SE/53/2023-24 February 10, 2024 The National Stock Exchange of India Limited BSE Limited "Exchange Plaza", C-1, Block G Department of Corporate Services Bandra-Kurla Complex, Bandra (E) 1st Floor, Mumbai 400 051 P.J. Towers, Dalal Street, Mumbai 400 001 Symbol: AMRUTANJAN Scrip Code: 590006 Dea
Slide 2: Amrutanjan Health Care Limited Investor Presentation
Amrutanjan Health Care Limited Investor Presentation Quarter & Period Ended 31st December 2023 Date: 9th February 2024
Slide 3: Contents
Contents a. Business Update 1. Segment Performance 2. Activities 3. Operations b. Financials 1. Q3 Performance 2. YTD Dec’23 Performance c. Management Commentary Investor Presentation | Quarter & Period Ended 31st December 2023 2
Slide 4: Business Update
Business Update Investor Presentation | Quarter & Period Ended 31st December 2023 3
Slide 5: Segment Performance: OTC
Segment Performance: OTC Head Category Body Category Congestion Category • In MAT Dec’23*, the Head category reached 1673 • The Body category in MAT Dec ’23* is valued at • Our congestion category, post-packaging refresh, crores, with a value growth of 6.6%, outpacing volume 2917 crores, showing a v
Slide 6: Segment Performance: Women's Hygiene and Beverages
Segment Performance: Women’s Hygiene and Beverages Women’s Hygiene Category Beverages Category • Comfy achieved a revenue of Rs. 77.15 crores, marking a robust growth of 30.3% • Electro+, our rehydration brand, achieved a revenue of Rs. 16.11 in YTD Dec '23 compared to the same period last year. cro
Slide 7: New Products: Electro+ variants
New Products: Electro+ variants Electro+ Low Sugar Electro+ Lemon • Electro+ Low Sugar variant has low added sugar which makes it a perfect • Electro+ in a refreshing Lemon flavor contains 5 essential electrolytes drink for diabetic, health conscious consumers, athletes and fitness (Potassium, Sodiu
Slide 8: Activities: TV Media - OTC and Women's Hygiene
Activities: TV Media - OTC and Women’s Hygiene • In line with our consistent approach towards brand building, our TV media continued in Q3 FY 24 as well across categories and for all key brands. The objective of the campaign is to drive awareness and consideration (through claims) Head Body Congesti
Slide 9: Activities: Sampling and Visibility - OTC
Activities: Sampling and Visibility - OTC Sampling : Head and Body Visibility : Maha Strong Sampling : Relief Hot Drink • We continued with our sampling programme in • Project Shivaji was initiated to drive the GTM of the • The newly launched Relief Cold and Cough Hot this FY. We sampled our head an
Slide 10: Activities: Sampling and Visibility - Women's Hygiene
Activities: Sampling and Visibility - Women’s Hygiene School Sampling : Comfy Sanitary Napkin Sampling & Visibility : Comfy Period Pain Roll On • We continued with Project Disha this year and expanded school sampling • Being pioneers in pain relief for 130 years, we developed a new product activity
Slide 11: Activities: Digital - Across brands and mediums
Activities: Digital - Across brands and mediums Global Influencers Market Received 6.7 Million views 4.8L unique users reached Investor Presentation | Quarter & Period Ended 31st December 2023 Leading Fitness Influencers 22 Million impressions 10
Slide 12: Activities: PR - Across brands and mediums
Activities: PR - Across brands and mediums Best Health Care Brand by Economic Times Brand Amrutanjan Growth Legacy World of Amrutanjan Store in Delhi Comfy Project Disha – School Sampling World of Amrutanjan Store in Ahmedabad Investor Presentation | Quarter & Period Ended 31st December 2023 11
Slide 13: Recognition: Best Health Care Brand 2023
Recognition: Best Health Care Brand 2023 Amrutanjan has been felicitated with ET “Best Healthcare Brands Award – 2023”. We are among the top 200 healthcare companies out of a 1000 healthcare companies in India. Investor Presentation | Quarter & Period Ended 31st December 2023 12
Slide 14: Omni Channel: Online and Offline presence
Omni Channel: Online and Offline presence Online Store Mobile App Physical Stores Mylapore, Chennai Comfy App Rajouri Gardens, Delhi Judges Bungalow Road, Ahmedabad www.worldofamrutanjan.com Investor Presentation | Quarter & Period Ended 31st December 2023 13
Slide 15: Operations Update: Human Capital - Key Initiatives
Operations Update: Human Capital - Key Initiatives HR Digitization Gender Inclusion Succession Planning • Darwin Box, a human capital management • Hire upto 10% women employees in the next 3 • Succession policy rolled out. High potential solution rolled out for digitizing all human capital years tal
Slide 16: Operations Update: Sales and Distribution
Operations Update: Sales and Distribution Distribution Sales Credit Control Distribution Points Total Lines Sold Increased 9% in Dec 23 Increased by 80% Vs Mar 23 Debtors 42% of the sales through Direct Outlets Coverage Internal Sales Value advance payment From 2.7 lac to 3.1 lac Increased by 40% ou
Slide 17: Operations Update: IT
Operations Update: IT IT Projects SAP IT Operation Cockpit Enterprise Wide SAP Health monitoring of Rollout AHCL Critical Assets Security Operation Center Identify, Analyze, Assess, Treat, Monitor & Report All IT Risks/Incidents Investor Presentation | Quarter & Period Ended 31st December 2023 16
Slide 18: Financials
Financials Investor Presentation | Quarter & Period Ended 31st December 2023 17
Slide 19: Financials – Q3 FY24
Financials – Q3 FY24 (Rs. in Crores) Net Sales Profit Before Tax Profit After Tax 23.71 116.99 17.45 97.65 14.50 10.71 Q3 FY24 Q3 FY23 Q3 FY24 Q3 FY23 Q3 FY24 Q3 FY23 Growth: 19.81% Growth: 63.52% Growth: 62.93% Investor Presentation | Quarter & Period Ended 31st December 2023 18
Slide 20: Financials – Q3 FY24
Financials – Q3 FY24 (Rs. in Crores) Net Sales - OTC Net Sales - Beverages 111.79 5.18 93.51 3.65 Q3 FY24 Q3 FY23 Q3 FY24 Q3 FY23 Growth: 19.55% Growth: 41.92% Net Sales - Comfy Net Sales - Electro Plus 4.86 30.18 3.04 18.06 Q3 FY24 Q3 FY23 Q3 FY24 Q3 FY23 Growth: 67.11% Growth: 59.87% Investor Pres
Slide 21: Financials – YTD Dec'23
Financials – YTD Dec’23 (Rs. in Crores) Net Sales Profit Before Tax Profit After Tax 294.17 279.32 31.31 42.34 27.14 37.17 YTD Dec'23 YTD Dec'22 YTD Dec'23 YTD Dec'22 YTD Dec'23 YTD Dec'22 Growth: 5.32% Growth: 13.91% Growth: 15.36% Investor Presentation | Quarter & Period Ended 31st December 2023 2
Slide 22: Expenses – YTD Dec'23
Expenses – YTD Dec’23 (Rs. in Crores) Employee Benefit Expenses 35.23 36.44 YTD Dec'23 YTD Dec'22 Decrease: 3.32% Advertisement & Selling Expenses Other Expenses 45.45 38.05 37.22 35.14 YTD Dec'23 YTD Dec'22 YTD Dec'23 YTD Dec'22 Decrease: 18.11% Increase: 8.28% Investor Presentation | Quarter & Per
Slide 23: Financials – YTD Dec'23 – OTC Division
Financials – YTD Dec’23 – OTC Division (Rs. in Crores) Net Sales - OTC Notes: 272.02 260.16 • Majority of raw material prices are lower than YTD Dec’22. Menthol price is marginally higher than YTD Dec’22. YTD Dec'23 YTD Dec'22 • Majority of packing material prices Growth: 4.56% are lower than YTD De
Slide 24: Financials – YTD Dec'23 – Beverage Division
Financials – YTD Dec’23 – Beverage Division (Rs. in Crores) Net Sales - Beverages Notes: 21.32 17.62 • Raw Material prices are marginally lower when compared to YTD Dec’22. YTD Dec'23 YTD Dec'22 • Major Packing Material prices are lower when compared to YTD Growth: 20.99% Dec’22. Net Sales - Electro
Slide 25: Management Commentary
Management Commentary Investor Presentation | Quarter & Period Ended 31st December 2023 24
Slide 26: Management Commentary
Management Commentary • We are seeing balm sales finally pick up in Q3 and expect to see sales continue in the coming quarters. • Our closing stock continues to be maintained at 50 days levels compared to 60 days and above in the earlier periods. • Our largest balm SKU -8ml- grew by double digits in
Slide 27: Investor Presentation | Quarter & Period Ended 31st December 2023
Investor Presentation | Quarter & Period Ended 31st December 2023 26
Amrutanjan Health Care — Q3 FY24 Earnings Presentation on 6ix